Amanote Research
Register
Sign In
De-Repression of the P21 Promoter in Prostate Cancer Cells by an Isothiocyanate via Inhibition of HDACs and C-Myc
International Journal of Oncology
- Greece
doi 10.3892/ijo_00000018
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
January 1, 1992
Authors
L. G. Wang
Publisher
Spandidos Publications
Related search
MicroRNA-449a Enhances Radiosensitivity by Downregulation of C-Myc in Prostate Cancer Cells
Scientific Reports
Multidisciplinary
An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis
Cancer Cell
Cancer Research
Oncology
Cell Biology
P53 Mutant-Type in Human Prostate Cancer Cells Determines the Sensitivity to Phenethyl Isothiocyanate Induced Growth Inhibition
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
LincRNA-p21 Suppresses Development of Human Prostate Cancer Through Inhibition of PKM2
Cell Proliferation
Medicine
Cell Biology
C-Myc Promotes Tumor Proliferation and Anti‑apoptosis by Repressing P21 in Rhabdomyosarcomas
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Transcriptomic Analysis of Histone Methyltransferase Setd7 Knockdown and Phenethyl Isothiocyanate in Human Prostate Cancer Cells
Anticancer Research
Medicine
Cancer Research
Oncology
Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in C-Myc Regulation
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
USP2a Activation of MYC in Prostate Cancer
Cancer Discovery
Oncology
Wedelolactone, an Anti-Inflammatory Botanical, Interrupts C-Myc Oncogenic Signaling and Synergizes With Enzalutamide to Induce Apoptosis in Prostate Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
